Robert Fildes, Former President of Biogen Idec, Inc. (Massachusetts) and Cetus, Joins Vaxart, Inc. Board
SAN FRANCISCO--(BUSINESS WIRE)--Vaxart, Inc., a biotechnology company focused on the development of oral vaccines, announced that Robert Fildes, PhD, has been appointed to the board of directors.